
- Tissue
- Umbilical cord (artery)
- Disease
- Normal umbilical artery endothelium (primary cells; non-tumorigenic; neonatal)
- Metastatic site
- Not applicable (normal, non-tumorigenic primary cell)
- Synonyms
- HUAEC, Human umbilical artery endothelial cells, provitro 1210112
Documents
Human umbilical artery endothelial cells (HUAEC)
Primary cell · Product number 300698
The arterial counterpart to HUVEC
Customization / Recommendations
- Human umbilical artery endothelial cells (HUAEC)Primary cell€910.00
01General information
- Description
Primary Human Umbilical Artery Endothelial Cells (HUAEC) are isolated from the umbilical artery and provide an arterial counterpart to HUVEC. They are used to study arterial–venous differences in inflammation, nitric oxide signaling and fetal programming in pregnancy-related disorders.
Compared directly with HUVEC, HUAEC respond to inflammatory stimuli such as TNF-α with a distinct pattern of gene regulation, including differences in how they return to homeostasis after the stimulus is removed. This makes them well suited to test whether findings in venous endothelium also hold for arterial endothelium.
- Tissue
- Umbilical cord (artery)
- Disease
- Normal umbilical artery endothelium (primary cells; non-tumorigenic; neonatal)
- Metastatic site
- Not applicable (normal, non-tumorigenic primary cell)
- Applications
- Arterial–venous differences in inflammation and its resolution; Fetal programming: maternal obesity, oxidative stress and epigenetics; Nitric oxide, eNOS and arginase-2 regulation, epigenetic pharmacology; Angiogenesis assays (Matrigel tube formation, migration); Anti-proliferative screening of angiogenesis inhibitors (VEGF receptor 2)
- Synonyms
- HUAEC
- Human umbilical artery endothelial cells
- provitro 1210112
02Donor
- Donor age
- Newborn (umbilical cord)
- Ethnicity
- Lot-specific (see CoA)
03Classification
- Organism
- Human
- Sex
- Lot-specific
- Growth properties
- Adherent
- GMO status
- Non-GMO
- GMO status details
- No genetic modification; primary human endothelial cells isolated from umbilical artery. Not transformed or immortalized. Tested and confirmed negative for mycoplasma, bacteria, yeast, HIV-1/2, HBV, HCV.
- Biosafety level
- 1
04Characteristics
- Morphology
- Cobblestone (endothelial)
- Cell type
- Primary endothelial cells
- Tumourigenic
- No
- Doubling time
- approx. 24 to 36 hours (lot-specific; guaranteed ≥15 population doublings under ScienCell-recommended conditions)
05Handling and culture
- Culture medium
- Endothelial Cell Growth Medium
- Incubation atmosphere
37°C, 5% CO2, saturated humidity.
- Supplements
- ScienCell ECM #1001 is pre-supplemented with FBS, endothelial cell growth supplement (ECGS), and antibiotics as specified in the medium kit; no additional serum supplement needed. Coat culture vessels with fibronectin (1–2 µg/cm²) before seeding.
- Dissociation reagent
- Subculture reagents as recommended on the certificate of analysis
- Flask coating
- Fibronectin coating required (1–2 µg/cm²; incubate at 37°C for 30 min, aspirate excess before seeding)
- Subculturing
Subculture the cells at about 75 % confluence. Denser cultures undergo irreversible contact inhibition and stop proliferating. Use the subculture reagents recommended on the certificate of analysis.
- Split ratio
- 1 to 3
- Seeding density
- More than 6,000 cells/cm²
- Fluid renewal
- 24 hours after seeding, then every 48 to 72 hours
- Post-thaw recovery
Post-thaw viability ≥ 70 % viable cells. More than 80 % confluence within the expected recovery period.
- Thawing and culturing
Thaw the cryovial quickly in a 37 °C water bath, swirling gently. Just before the last ice has melted, move the vial to a laminar flow hood and decontaminate its outer surface.
Transfer the cell suspension into a 15 ml centrifuge tube, add 10 ml of Endothelial Cell Growth Medium and centrifuge at 250 × g for 5 minutes.
Remove the supernatant and resuspend the cell pellet in 10 ml of Endothelial Cell Growth Medium. Check cell number and viability.
Divide the suspension between two 25 cm² culture flasks (5 ml each). Using two flasks reduces the risk of losing all cells if a passage fails.
Incubate at 37 °C, 5 % CO₂ and saturated humidity, with the screw caps opened by half a turn for gas exchange.
Change the medium after 24 hours to remove unattached cells, then every 48 to 72 hours, using pre-warmed medium only.
Subculture the cells at about 75 % confluence. Denser cultures undergo irreversible contact inhibition and stop proliferating. Use the subculture reagents recommended on the certificate of analysis.
Recommended seeding density: more than 6,000 cells/cm².
06Quality control and cryopreservation
- Sterility
Mycoplasma contamination is excluded by PCR.
To ensure there is no bacterial, fungal or yeast contamination, cultures are subjected to visual inspection.
- Freeze medium
- As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
- Storage conditions
For long-term preservation, store vials in liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable for up to one week only.
- Shipping conditions
Cryopreserved primary cells are shipped on dry ice. On receipt, check the cryovial for damage and transfer it without delay to appropriate storage.
07Expression and susceptibility
- Surface antigens
- CD31 (PECAM-1) +; vWF (Factor VIII) +; Dil-Ac-LDL uptake +; Ephrin-B2 + (arterial marker); DLL4 + (arterial marker); Notch4 + (arterial marker); NRP1 + (arterial marker)
- Receptors expressed
- VEGFR2 (KDR); VEGFR1 (Flt1); TIE-2; NRP1 (arterial-specific); Notch receptor (Notch1, Notch4)
- Viruses
- Free of HIV-1, HIV-2, HBV, HCV (confirmed negative; ScienCell #8010 QC)
08Identifiers
- Citation
- Human umbilical artery endothelial cells (HUAEC) (Cytion catalog number 300698)
- NCBI TaxID
- 9606
- Cellosaurus
- Not assigned
09Legal and safety
- Safety precautions
- When planning to store a cryovial in liquid nitrogen for future thawing, it is mandatory to adhere to stringent safety measures. Appropriate protective gloves and clothing are essential, and the use of a face mask or safety goggles is required during the transfer of frozen samples to or from the liquid nitrogen tank. This is to mitigate the risk of injury from potential cryovial explosions upon removal, which can result in the projection of sharp fragments. Primary cells are of human origin, and no known test procedure can ensure the complete absence of infectious agents. Handle all products as potentially infectious.
- Warranty
At Cytion, we stand behind the quality and viability of our products. We guarantee that our cells will be viable at the start of culture for 60 days after shipment from our facilities. We assure that all materials conform to the specifications described in the Certificate of Analysis and/or Product Sheet.
For full details, please refer to our Warranty Statement.
- Material Transfer Agreement required
- Yes